These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4069813)

  • 21. Tobramycin in patients with cystic fibrosis. Adjustment in dosing interval for effective treatment.
    Horrevorts AM; de Witte J; Degener JE; Dzoljic-Danilovic G; Hop WC; Driessen O; Michel MF; Kerrebijn KF
    Chest; 1987 Nov; 92(5):844-8. PubMed ID: 3665599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum and lower respiratory tract drug concentrations after tobramycin inhalation in young children with cystic fibrosis.
    Rosenfeld M; Gibson R; McNamara S; Emerson J; McCoyd KS; Shell R; Borowitz D; Konstan MW; Retsch-Bogart G; Wilmott RW; Burns JL; Vicini P; Montgomery AB; Ramsey B
    J Pediatr; 2001 Oct; 139(4):572-7. PubMed ID: 11598606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and safety of tobramycin after once-daily administration in patients with cystic fibrosis.
    Bates RD; Nahata MC; Jones JW; McCoy K; Young G; Cox S; Barson WJ
    Chest; 1997 Nov; 112(5):1208-13. PubMed ID: 9367459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemodialysis elimination rates and clearance of gentamicin and tobramycin.
    Matzke GR; Halstenson CE; Keane WF
    Antimicrob Agents Chemother; 1984 Jan; 25(1):128-30. PubMed ID: 6703676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tobramycin once- vs thrice-daily for elective intravenous antipseudomonal therapy in pediatric cystic fibrosis patients.
    Riethmueller J; Ballmann M; Schroeter TW; Franke P; von Butler R; Claass A; Junge S; Doering G; Stern M;
    Infection; 2009 Oct; 37(5):424-31. PubMed ID: 19756418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial chemotherapy in patients with cystic fibrosis.
    Guggenbichler JP; Schneeberger J
    Infection; 1987; 15(5):397-402. PubMed ID: 3692614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Individualizing gentamicin dosage in patients with cystic fibrosis: limitations to pharmacokinetic approach.
    Hendeles L; Iafrate RP; Stillwell PC; Mangos JA
    J Pediatr; 1987 Feb; 110(2):303-10. PubMed ID: 3806307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Individualized aminoglycoside dosage regimens in patients with cystic fibrosis.
    Delage G; Desautels L; Legault S; Lasalle R; Lapierre JG; Lamarre A; Masson P; Spier S
    Drug Intell Clin Pharm; 1988 May; 22(5):386-9. PubMed ID: 3391108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. Aminoglycosides.
    Young DC; Zobell JT; Stockmann C; Waters CD; Ampofo K; Sherwin CM; Spigarelli MG
    Pediatr Pulmonol; 2013 Nov; 48(11):1047-61. PubMed ID: 24000183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Once-daily gentamicin dosing in pediatric patients without cystic fibrosis.
    McDade EJ; Wagner JL; Moffett BS; Palazzi DL
    Pharmacotherapy; 2010 Mar; 30(3):248-53. PubMed ID: 20180608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cumulative and acute toxicity of repeated high-dose tobramycin treatment in cystic fibrosis.
    Pedersen SS; Jensen T; Osterhammel D; Osterhammel P
    Antimicrob Agents Chemother; 1987 Apr; 31(4):594-9. PubMed ID: 3606063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of piperacillin alone versus piperacillin plus tobramycin for treatment of respiratory infections in children with cystic fibrosis.
    McCarty JM; Tilden SJ; Black P; Craft JC; Blumer J; Waring W; Halsey NA
    Pediatr Pulmonol; 1988; 4(4):201-4. PubMed ID: 3393383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of chronic pseudomonas aeruginosa infection in cystic fibrosis patients with ceftazidime and tobramycin.
    Heilesen AM; Permin H; Koch C; Høiby N
    Scand J Infect Dis; 1983; 15(3):271-6. PubMed ID: 6417770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and safety of an 8 week continuous treatment with once-daily versus twice-daily inhalation of tobramycin in cystic fibrosis patients.
    van Koningsbruggen-Rietschel S; Heuer HE; Merkel N; Posselt HG; Staab D; Sieder C; Ziegler J; Krippner F; Rietschel E
    J Antimicrob Chemother; 2016 Mar; 71(3):711-7. PubMed ID: 26626719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin.
    Powell SH; Thompson WL; Luthe MA; Stern RC; Grossniklaus DA; Bloxham DD; Groden DL; Jacobs MR; DiScenna AO; Cash HA; Klinger JD
    J Infect Dis; 1983 May; 147(5):918-32. PubMed ID: 6860416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis.
    Vic P; Ategbo S; Turck D; Husson MO; Launay V; Loeuille GA; Sardet A; Deschildre A; Druon D; Arrouet-Lagande C
    Arch Dis Child; 1998 Jun; 78(6):536-9. PubMed ID: 9713009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensive treatment of pseudomonas chest infection in cystic fibrosis: a comparison of tobramycin and ticarcillin, and netilmicin and ticarcillin.
    Conway SP; Miller MG; Ramsden C; Littlewood JM
    Acta Paediatr Scand; 1985 Jan; 74(1):107-13. PubMed ID: 3885674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tobramycin elimination rate change from first to later doses in older cystic fibrosis patients.
    Horner GW; Stempel DA
    Drug Intell Clin Pharm; 1987 Mar; 21(3):276-8. PubMed ID: 3569027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aminoglycoside dosage in pediatric patients:considerations regarding pharmacokinetic-based dose adjustment in patients requiring high versus low dose therapy.
    Leff RD; Roberts RJ
    Dev Pharmacol Ther; 1981; 3(4):242-50. PubMed ID: 7344881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic profile of once daily intravenous tobramycin in children with cystic fibrosis.
    Massie J; Cranswick N
    J Paediatr Child Health; 2006 Oct; 42(10):601-5. PubMed ID: 16972966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.